Disclaimer: Please note that compounded medications are not reviewed by the FDA for safety, quality, or efficacy
Colleen McCabe, PharmD, BCOP, and Lindsay Mundy, PharmD, BCOP, led an engaging exploration of the benefits and potential pitfalls with the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in an oncology setting in their presentation, GLP-1s in Oncology: Miracle, Misdirection, or Missed Opportunity
If youre considering body contouring treatments at Vermont Med Spa and are currently taking semaglutide (a medication commonly prescribed for weight loss and type 2 diabetes), you may be wondering how these two approaches to achieving your aesthetic goals work together
We have built a platform that removes the barriers to high-quality care
10.1073/pnas.2025847118 Proc
Like the FDA panel, peptide marketing is rife with conflicts of interest